MX2017004828A - Composicion oftalmica que comprende ciclosporina y trehalosa. - Google Patents
Composicion oftalmica que comprende ciclosporina y trehalosa.Info
- Publication number
- MX2017004828A MX2017004828A MX2017004828A MX2017004828A MX2017004828A MX 2017004828 A MX2017004828 A MX 2017004828A MX 2017004828 A MX2017004828 A MX 2017004828A MX 2017004828 A MX2017004828 A MX 2017004828A MX 2017004828 A MX2017004828 A MX 2017004828A
- Authority
- MX
- Mexico
- Prior art keywords
- ophthalmic composition
- cyclosporine
- trehalose
- ophthalmoxerosis
- same
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a una composición oftálmica que comprende ciclosporina y trehalosa como componentes efectivos, un método para producir el mismo, un método para prevenir, mejorar o tratar el fallo causado por oftalmoxerosis administrando el mismo, y un uso para el mismo. La composición oftálmica de acuerdo con la presente invención tiene una combinación de efectos superiores sobre la oftalmoxerosis, que puede ser causada por diversos factores tales como aire seco, inflamación, conservantes, etc., y se coloca en una variedad de estados o condiciones.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020140141089A KR101587412B1 (ko) | 2014-10-17 | 2014-10-17 | 사이클로스포린 및 트레할로스를 포함하는 안과용 조성물 |
| PCT/KR2015/011048 WO2016060532A1 (ko) | 2014-10-17 | 2015-10-19 | 사이클로스포린 및 트레할로스를 포함하는 안과용 조성물 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2017004828A true MX2017004828A (es) | 2017-07-20 |
| MX379500B MX379500B (es) | 2025-03-10 |
Family
ID=55308741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017004828A MX379500B (es) | 2014-10-17 | 2015-10-19 | Composición oftálmica que comprende ciclosporina y trehalosa. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10039803B2 (es) |
| EP (1) | EP3213763B1 (es) |
| JP (1) | JP6611803B2 (es) |
| KR (1) | KR101587412B1 (es) |
| CN (1) | CN106999543B (es) |
| AU (1) | AU2015331089B2 (es) |
| BR (1) | BR112017007813A2 (es) |
| ES (1) | ES2773641T3 (es) |
| MX (1) | MX379500B (es) |
| PH (1) | PH12017500615A1 (es) |
| RU (1) | RU2700927C2 (es) |
| SA (1) | SA517381318B1 (es) |
| SG (1) | SG11201704695WA (es) |
| WO (1) | WO2016060532A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3280412T (lt) * | 2015-04-09 | 2019-11-25 | Laboratori Baldacci Spa | Pirolidono karboksirūgštis (pkr), skirta naudoti oftalmologijoje |
| KR20180030323A (ko) * | 2016-09-13 | 2018-03-22 | 주식회사 코아팜바이오 | 사이클로스포린의 안구필름 제형 |
| KR102268319B1 (ko) * | 2016-12-29 | 2021-06-23 | (주)휴온스 | 지속성 점안제 조성물 |
| ES3054066T3 (en) * | 2017-06-09 | 2026-01-29 | Omnivision Gmbh | Composition for the treatment of dry eye |
| US10702578B2 (en) | 2017-08-02 | 2020-07-07 | Shilpa Medicare Limited | Ophthalmic compositions of cyclosporine |
| CN113069556B (zh) * | 2021-04-12 | 2022-04-08 | 青岛大学附属医院 | 一种枝接那他霉素的氧化海藻酸纤维膜及其制备方法 |
| CN113262235B (zh) * | 2021-04-25 | 2022-10-21 | 自然资源部第三海洋研究所 | 新琼寡糖在治疗眼科疾病方面的新用途 |
| KR102764433B1 (ko) * | 2022-03-28 | 2025-02-07 | 경북대학교 산학협력단 | 태반유래 양막상피세포에서 포집된 세포외 소포 기반의 안과용 국소 약물전달체 |
| WO2023229332A1 (ko) * | 2022-05-24 | 2023-11-30 | 줄리아 연구소 주식회사 | 트레할로스를 포함하는 망막 질환 또는 퇴행성 뇌 질환의 예방, 개선 또는 치료용 건강식품 조성물 및 약학적 조성물 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6290991B1 (en) * | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
| CA2355814C (en) * | 2000-09-14 | 2010-06-29 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Pharmaceutical composition for ophthalmic use |
| JP4982643B2 (ja) * | 2000-09-14 | 2012-07-25 | 株式会社林原 | 眼科用医薬組成物 |
| DE102006051512A1 (de) * | 2005-12-06 | 2007-06-14 | Pari GmbH Spezialisten für effektive Inhalation | Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin |
| US20080146497A1 (en) * | 2006-07-25 | 2008-06-19 | Graham Richard S | Cyclosporin Compositions |
| CN101049504B (zh) * | 2007-04-05 | 2010-05-19 | 广州立恩生物科技有限公司 | 一种脂质体药物载体及其制备方法 |
| CA3014633C (en) * | 2007-10-08 | 2022-05-17 | Aurinia Pharmaceuticals Inc. | Ophthalmic compositions comprising calcineurin inhibitors or mtor inhibitors |
| US20110070293A1 (en) * | 2009-09-23 | 2011-03-24 | Javeri Indu | Methods for the Preparation of Liposomes Comprising Docetaxel |
| TWI531377B (zh) * | 2011-02-08 | 2016-05-01 | 艾伯維有限公司 | 骨關節炎及疼痛之治療 |
| US20130029919A1 (en) | 2011-07-26 | 2013-01-31 | Allergan, Inc. | Two part formulation system for opthalmic delivery |
| KR101211902B1 (ko) | 2012-04-30 | 2012-12-13 | 주식회사 휴온스 | 사이클로스포린 함유 무자극성 나노에멀젼 안약 조성물 |
| HRP20230559T1 (hr) * | 2012-08-24 | 2023-09-15 | Sun Pharmaceutical Industries Limited | Oftalmička formulacija polioksil lipida ili polioksil masne kiseline i tretman očnih stanja |
| KR101492447B1 (ko) * | 2013-05-20 | 2015-02-23 | 주식회사태준제약 | 사이클로스포린을 함유하는 나노에멀젼 점안 조성물 및 그의 제조 방법 |
| WO2015013330A2 (en) * | 2013-07-22 | 2015-01-29 | Kineta One, Llc | Ophthalmic uses of toxin-based therapeutic peptides and pharmaceutical compositions thereof |
| CA2955037A1 (en) * | 2014-07-18 | 2016-01-21 | Allergan, Inc. | Suspension compositions of cyclosporin a for subconjunctival and periocular injection |
-
2014
- 2014-10-17 KR KR1020140141089A patent/KR101587412B1/ko active Active
-
2015
- 2015-10-19 US US15/519,497 patent/US10039803B2/en active Active
- 2015-10-19 JP JP2017520527A patent/JP6611803B2/ja not_active Expired - Fee Related
- 2015-10-19 SG SG11201704695WA patent/SG11201704695WA/en unknown
- 2015-10-19 AU AU2015331089A patent/AU2015331089B2/en not_active Ceased
- 2015-10-19 EP EP15850677.4A patent/EP3213763B1/en active Active
- 2015-10-19 WO PCT/KR2015/011048 patent/WO2016060532A1/ko not_active Ceased
- 2015-10-19 ES ES15850677T patent/ES2773641T3/es active Active
- 2015-10-19 MX MX2017004828A patent/MX379500B/es unknown
- 2015-10-19 RU RU2017116974A patent/RU2700927C2/ru active
- 2015-10-19 BR BR112017007813A patent/BR112017007813A2/pt active Search and Examination
- 2015-10-19 CN CN201580056326.9A patent/CN106999543B/zh not_active Expired - Fee Related
-
2017
- 2017-04-03 PH PH12017500615A patent/PH12017500615A1/en unknown
- 2017-04-16 SA SA517381318A patent/SA517381318B1/ar unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP6611803B2 (ja) | 2019-11-27 |
| EP3213763A1 (en) | 2017-09-06 |
| RU2017116974A (ru) | 2018-11-21 |
| RU2017116974A3 (es) | 2019-04-17 |
| CN106999543B (zh) | 2021-01-05 |
| EP3213763B1 (en) | 2020-01-08 |
| ES2773641T3 (es) | 2020-07-13 |
| SA517381318B1 (ar) | 2020-09-09 |
| WO2016060532A1 (ko) | 2016-04-21 |
| BR112017007813A2 (pt) | 2017-12-19 |
| MX379500B (es) | 2025-03-10 |
| SG11201704695WA (en) | 2017-07-28 |
| US20170224766A1 (en) | 2017-08-10 |
| AU2015331089B2 (en) | 2020-10-15 |
| JP2017531022A (ja) | 2017-10-19 |
| EP3213763A4 (en) | 2018-07-18 |
| AU2015331089A1 (en) | 2017-06-08 |
| CN106999543A (zh) | 2017-08-01 |
| US10039803B2 (en) | 2018-08-07 |
| RU2700927C2 (ru) | 2019-09-24 |
| PH12017500615B1 (en) | 2017-09-04 |
| KR101587412B1 (ko) | 2016-01-21 |
| PH12017500615A1 (en) | 2017-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2017004828A (es) | Composicion oftalmica que comprende ciclosporina y trehalosa. | |
| CO2018006714A2 (es) | 3-azabiciclo[3.1.0]hexanos sustituidos como inhibidores de cetohexoquinasa | |
| CL2018003588A1 (es) | Uso de inhibidores de miostatina y terapias de combinación. | |
| MX2018005829A (es) | Composiciones para tratar el cabello. | |
| AR096478A1 (es) | Composiciones para el tratamiento de superficie que comprenden tintes fotocromáticos | |
| MX2016013034A (es) | Composicion detergente. | |
| CO2017005034A2 (es) | Tratamiento de convulsiones con fosfatasa alcalina recombinante | |
| CL2016000055A1 (es) | Métodos para tratar o prevenir afecciones oftalmológicas | |
| MX2019005402A (es) | Terapias de combinacion del inhibidor de arginasa. | |
| CL2016000326A1 (es) | Composiciones y método para tratar condiciones asociadas con el complemento | |
| CR20150376A (es) | Compuestos sustituidos de pirrolopirimidina, compuestos de los mismos y metodos de tratamiento con los mismos | |
| UY36703A (es) | Composiciones y métodos para la administración de un polinucleótido en una planta | |
| EA202090632A1 (ru) | Способы и композиции для лечения расстройств с использованием фоллистатиновых полипептидов | |
| BR112016023851A2 (pt) | ?composição de revestimento de duas partes e método para revestir uma superfície? | |
| CR20170219A (es) | Inhibidores del bromodominio | |
| MX2015011281A (es) | Composiciones de inh-c1 y metodos para la prevencion y el tratamiento de trastornos asociados con la deficiencia del inhibidor de c1 esterasa. | |
| MX2015016627A (es) | Vacuna para la malaria. | |
| CL2013003349A1 (es) | Composicion que comprende una combinacion sinergica de un fungicida polienico y por lo menos un lipopeptido; y metodo para controlar patogenos fungicos. | |
| DOP2016000336A (es) | Derivados de isoindolina para uso en el tratamiento de una infeccion viral | |
| CL2015002897A1 (es) | Inhibidores de bace1 | |
| MX2016013236A (es) | Formulacion inmunosupresora. | |
| MX374385B (es) | Apilimod para uso en el tratamiento de melanoma. | |
| CL2016001210A1 (es) | Análogos de bicalutamida o (s)- bicalutamida como compuestos activadores de la exocitosis para su uso en el tratamiento de un desorden de acúmulo lisosomal o glucogenosis. | |
| MX383944B (es) | Composiciones para el cuidado personal. | |
| MX2017007000A (es) | Composiciones que comprenden acido 15-hidroxieicosapentaenoico (15-hepe) y metodos para tratar o prevenir la fibrosis usando las mismas. |